Stress, caffeine and ethanol trigger transient neurological dysfunction through shared mechanisms in a mouse calcium channelopathy

Neurobiology of Disease

Volumn 50, Issue 1, 2013, Pages 151-159

  Raike, Robert S ^a   Weisz, Catherine ^b   Hoebeek, Freek E ^c   Terzi, Matthew C ^a   De Zeeuw, Chris I ^c,d   van den Maagdenberg, Arn M ^e   Jinnah, H A ^a   Hess, Ellen J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcium channel; Cerebellum; Channelopathy; Episodic; Purkinje; Tottering

Indexed keywords

ALCOHOL; CAFFEINE; CALCIUM CHANNEL; CALCIUM CHANNEL CAV2.1; RYANODINE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CALCIUM CHANNELOPATHY; CEREBELLUM; CONTROLLED STUDY; DISEASE COURSE; GENETIC DISORDER; MENTAL STRESS; MOUSE; NEUROANATOMY; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL STRESS; PRIORITY JOURNAL; PURKINJE CELL; SYMPTOM;

ANIMALS; CAFFEINE; CALCIUM CHANNELS, N-TYPE; CENTRAL NERVOUS SYSTEM AGENTS; CHANNELOPATHIES; DYSTONIA; ETHANOL; FEMALE; MALE; MICE; MICE, MUTANT STRAINS; MICE, NEUROLOGIC MUTANTS; MOTOR ACTIVITY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; STRESS, PSYCHOLOGICAL;

EID: 84868481098     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.09.005     Document Type: Article

References (54)

1. Alvina K., Khodakhah K. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J. Neurosci. 2010, 30:7258-7268.
2. Bhatia K.P. Familial (idiopathic) paroxysmal dyskinesias: an update. Semin. Neurol. 2001, 21:69-74.
3. Bhatia K.P., Griggs R.C., Ptacek L.J. Episodic movement disorders as channelopathies. Mov. Disord. 2000, 15:429-433.
4. Campbell D.B., Hess E.J. Cerebellar circuitry is activated during convulsive episodes in the tottering (tg/tg) mutant mouse. Neuroscience 1998, 85:773-783.
5. Cannon S.C. Pathomechanisms in channelopathies of skeletal muscle and brain. Annu. Rev. Neurosci. 2006, 29:387-415.
6. Chen G., Popa L.S., Wang X., Gao W., Barnes J., Hendrix C.M., Hess E.J., Ebner T.J. Low-frequency oscillations in the cerebellar cortex of the tottering mouse. J. Neurophysiol. 2009, 101:234-245.
7. Chen X., Tang T.S., Tu H., Nelson O., Pook M., Hammer R., Nukina N., Bezprozvanny I. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J. Neurosci. 2008, 28:12713-12724.
8. Cheng H., Lederer W.J. Calcium sparks. Physiol. Rev. 2008, 88:1491-1545.
9. Crews F.T., Morrow A.L., Criswell H., Breese G. Effects of ethanol on ion channels. Int. Rev. Neurobiol. 1996, 39:283-367.
10. da Silva Torres I.L., Bonan C.D., Crema L., De Leon Nunes M., Battastini A.M., Sarkis J.J., Dalmaz C., Ferreira M.B. Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats. Eur. J. Pharmacol. 2003, 481:197-201.
11. Daly J.W. Caffeine analogs: biomedical impact. Cell. Mol. Life Sci. 2007, 64:2153-2169.
12. Devanagondi R., Egami K., LeDoux M.S., Hess E.J., Jinnah H.A. Neuroanatomical substrates for paroxysmal dyskinesia in lethargic mice. Neurobiol. Dis. 2007, 27:249-257.
13. Fan X., Hess E.J. D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD. Neurobiol. Dis. 2007, 26:201-211.
14. Fletcher C.F., Lutz C.M., O'Sullivan T.N., Shaughnessy J.D., Hawkes R., Frankel W.N., Copeland N.G., Jenkins N.A. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996, 87:607-617.
15. Frucht M.M., Quigg M., Schwaner C., Fountain N.B. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000, 41:1534-1539.
16. Fureman B.E., Hess E.J. Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathy. Neurobiol. Dis. 2005, 20:227-232.
17. Fureman B.E., Jinnah H.A., Hess E.J. Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering. Pharmacol. Biochem. Behav. 2002, 73:631-637.
18. Haorah J., Knipe B., Gorantla S., Zheng J., Persidsky Y. Alcohol-induced blood-brain barrier dysfunction is mediated via inositol 1,4,5-triphosphate receptor (IP3R)-gated intracellular calcium release. J. Neurochem. 2007, 100:324-336.
19. Hoebeek F.E., Stahl J.S., van Alphen A.M., Schonewille M., Luo C., Rutteman M., van den Maagdenberg A.M., Molenaar P.C., Goossens H.H., Frens M.A., De Zeeuw C.I. Increased noise level of purkinje cell activities minimizes impact of their modulation during sensorimotor control. Neuron 2005, 45:953-965.
20. Hsu D.A., Stafstrom C.E., Rowley H.A., Kiff J.E., Dulli D.A. Hemiplegic migraine: hyperperfusion and abortive therapy with intravenous verapamil. Brain Dev. 2008, 30:86-90.
21. Iannetti P., Parisi P., Spalice A., Ruggieri M., Zara F. Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res. 2009, 85:89-95.
22. Jen J.C., Graves T.D., Hess E.J., Hanna M.G., Griggs R.C., Baloh R.W. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 2007, 130:2484-2493.
23. Jinnah H.A., Sepkuty J.P., Ho T., Yitta S., Drew T., Rothstein J.D., Hess E.J. Calcium channel agonists and dystonia in the mouse. Mov. Disord. 2000, 15:542-551.
24. Kano M., Garaschuk O., Verkhatsky A., Konnerth A. Ryanodine receptor-mediated intracellular calcium release in rat cerebellar Purkinje neurons. J. Physiol. 1995, 487:1-16.
25. Kirischuk S., Matiash V., Kulik A., Voitenko N., Kostyuk P., Verkhratsky A. Activation of P2-purino-, alpha 1-adreno and H1-histamine receptors triggers cytoplasmic calcium signalling in cerebellar Purkinje neurons. Neuroscience 1996, 73:643-647.
26. 2+ activation of the ryanodine receptor. Biochem. J. 2008, 414:441-452.
27. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 1999, 46:1167-1180.
28. Kumar S., Porcu P., Werner D.F., Matthews D.B., Diaz-Granados J.L., Helfand R.S., Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 2009, 205:529-564.
29. Links T.P., Arnoldus E.P., Wintzen A.R., van der Hoeven J., Gerritsen J.J., Brandenburg H.C. The calcium channel blocker verapamil in hypokalemic periodic paralysis. Muscle Nerve 1998, 21:1564-1565.
30. Liu J., Tang T.S., Tu H., Nelson O., Herndon E., Huynh D.P., Pulst S.M., Bezprozvanny I. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J. Neurosci. 2009, 29:9148-9162.
31. Minor T.R., Rowe M.K., Soames Job R.F., Ferguson E.C. Escape deficits induced by inescapable shock and metabolic stress are reversed by adenosine receptor antagonists. Behav. Brain Res. 2001, 120:203-212.
32. Muller C.E., Daly J.W. Stimulation of calcium release by caffeine analogs in pheochromocytoma cells. Biochem. Pharmacol. 1993, 46:1825-1829.
33. Nagatomo I., Hashiguchi W., Tominaga M., Akasaki Y., Uchida M., Takigawa M. Effects of MK-801, dantrolene, and FK506 on convulsive seizures and brain nitric oxide production in seizure-susceptible EL mice. Brain Res. 2001, 888:306-310.
34. Newton P.M., Messing R.O. Intracellular signaling pathways that regulate behavioral responses to ethanol. Pharmacol. Ther. 2006, 109:227-237.
35. 2+ channel gene CACNL1A4. Cell 1996, 87:543-652.
36. Paladini C.A., Williams J.T. Noradrenergic inhibition of midbrain dopamine neurons. J. Neurosci. 2004, 24:4568-4575.
37. Pizoli C.E., Jinnah H.A., Billingsley M.L., Hess E.J. Abnormal cerebellar signaling induces dystonia in mice. J. Neurosci. 2002, 22:7825-7833.
38. Ptacek L.J. Ion channel diseases: episodic disorders of the nervous system. Semin. Neurol. 1999, 19:363-369.
39. Riegel A.C., Williams J.T. CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons. Neuron 2008, 57:559-570.
40. Shirley T.L., Rao L.M., Hess E.J., Jinnah H.A. Paroxysmal dyskinesias in mice. Mov. Disord. 2008, 23:259-264.
41. Strupp M., Kalla R., Dichgans M., Freilinger T., Glasauer S., Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004, 62:1623-1625.
42. Swiader M., Borowicz K.K., Porebiak J., Kleinrok Z., Czuczwar S.J. Influence of agents affecting voltage-dependent calcium channels and dantrolene on the anticonvulsant action of the AMPA/kainate receptor antagonist LY 300164 in mice. Eur. Neuropsychopharmacol. 2002, 12:311-319.
43. Szczaluba K., Jurek M., Szczepanik E., Friedman A., Milewski M., Bal J., Mazurczak T. A family with paroxysmal nonkinesigenic dyskinesia: genetic and treatment issues. Pediatr. Neurol. 2009, 41:135-138.
44. Todorov B., van de Ven R.C., Kaja S., Broos L.A., Verbeek S.J., Plomp J.J., Ferrari M.D., Frants R.R., van den Maagdenberg A.M. Conditional inactivation of the Cacna1a gene in transgenic mice. Genesis 2006, 44:589-594.
45. 2+ channels in rat sensory neurons. J. Neurosci. 1997, 17:7404-7414.
46. Volsen S.G., Day F.C., McCormack A.L., Smith W., Craig P.J., Beattie R., Ince P.G., Shaw P.J., Ellis S.B., Gillespie A., Harpold M.M., Lodge D. The expression of neuronal voltage-dependent calcium channels in human cerebellum. Mol. Brain Res. 1995, 34:271-282.
47. Wakamori M., Yamazaki K., Matsunodaira H. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel. J. Biol. Chem. 1998, 52:34857-34867.
48. Walter J.T., Alvina K., Womack M.D., Chevez C., Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat. Neurosci. 2006, 9:389-397.
49. Weisz C.J., Raike R.S., Soria-Jasso L.E., Hess E.J. Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering. J. Neurosci. 2005, 25:4141-4145.
50. Westenbroek R.E., Sakurai T., Elliott E.M., Hell J.W., Starr T.V., Snutch T.P., Catterall W.A. Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels. J. Neurosci. 1995, 15:6403-6418.
51. Williams M., Jarvis M.F. Adenosine antagonists as potential therapeutic agents. Pharmacol. Biochem. Behav. 1988, 29:433-441.
52. Womack M.D., Khodakhah K. Dendritic control of spontaneous bursting in cerebellar Purkinje cells. J. Neurosci. 2004, 24:3511-3521.
53. Womack M.D., Walker J.W., Khodakhah K. Impaired calcium release in cerebellar Purkinje neurons maintained in culture. J. Gen. Physiol. 2000, 115:339-346.
54. Yamamori E., Iwasaki Y., Oki Y., Yoshida M., Asai M., Kambayashii M., Oiso Y., Nakashima N. Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion. Endocrinology 2004, 145:36-38.